115 related articles for article (PubMed ID: 38446659)
21. Inhibition of p16
Khatiwala RV; Zhang S; Li X; Devejian N; Bennett E; Cai C
Stem Cell Rev Rep; 2018 Aug; 14(4):612-625. PubMed ID: 29675777
[TBL] [Abstract][Full Text] [Related]
22. Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice.
Yousefzadeh MJ; Zhao J; Bukata C; Wade EA; McGowan SJ; Angelini LA; Bank MP; Gurkar AU; McGuckian CA; Calubag MF; Kato JI; Burd CE; Robbins PD; Niedernhofer LJ
Aging Cell; 2020 Mar; 19(3):e13094. PubMed ID: 31981461
[TBL] [Abstract][Full Text] [Related]
23. p15
Park SS; Lee YK; Park SH; Lim SB; Choi YW; Shin JS; Kim YH; Kim JH; Park TJ
Heliyon; 2023 Feb; 9(2):e13170. PubMed ID: 36785830
[TBL] [Abstract][Full Text] [Related]
24. CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis.
Capparelli C; Chiavarina B; Whitaker-Menezes D; Pestell TG; Pestell RG; Hulit J; Andò S; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2012 Oct; 11(19):3599-610. PubMed ID: 22935696
[TBL] [Abstract][Full Text] [Related]
25. Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma.
Salam R; Saliou A; Bielle F; Bertrand M; Antoniewski C; Carpentier C; Alentorn A; Capelle L; Sanson M; Huillard E; Bellenger L; Guégan J; Le Roux I
Nat Commun; 2023 Jan; 14(1):441. PubMed ID: 36707509
[TBL] [Abstract][Full Text] [Related]
26. Identification of Senescent Cells in the Bone Microenvironment.
Farr JN; Fraser DG; Wang H; Jaehn K; Ogrodnik MB; Weivoda MM; Drake MT; Tchkonia T; LeBrasseur NK; Kirkland JL; Bonewald LF; Pignolo RJ; Monroe DG; Khosla S
J Bone Miner Res; 2016 Nov; 31(11):1920-1929. PubMed ID: 27341653
[TBL] [Abstract][Full Text] [Related]
27. Increased p16
Sasaki M; Sato Y; Nakanuma Y
J Autoimmun; 2020 Feb; 107():102377. PubMed ID: 31812332
[TBL] [Abstract][Full Text] [Related]
28. The chemotherapeutic drug doxorubicin does not exacerbate p16
Postmus AC; Kruit JK; Eilers RE; Havinga R; Koster MH; Johmura Y; Nakanishi M; van de Sluis B; Jonker JW
Toxicol Appl Pharmacol; 2023 Jun; 468():116531. PubMed ID: 37088304
[TBL] [Abstract][Full Text] [Related]
29. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.
Baker DJ; Wijshake T; Tchkonia T; LeBrasseur NK; Childs BG; van de Sluis B; Kirkland JL; van Deursen JM
Nature; 2011 Nov; 479(7372):232-6. PubMed ID: 22048312
[TBL] [Abstract][Full Text] [Related]
30. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
[TBL] [Abstract][Full Text] [Related]
31. p16
Al-Khalaf HH; Aboussekhra A
Mol Carcinog; 2017 Mar; 56(3):985-999. PubMed ID: 27596953
[TBL] [Abstract][Full Text] [Related]
32. FOXA1 mediates p16(INK4a) activation during cellular senescence.
Li Q; Zhang Y; Fu J; Han L; Xue L; Lv C; Wang P; Li G; Tong T
EMBO J; 2013 Mar; 32(6):858-73. PubMed ID: 23443045
[TBL] [Abstract][Full Text] [Related]
33. Characterization of regulatory elements on the promoter region of p16(INK4a) that contribute to overexpression of p16 in senescent fibroblasts.
Wang W; Wu J; Zhang Z; Tong T
J Biol Chem; 2001 Dec; 276(52):48655-61. PubMed ID: 11598130
[TBL] [Abstract][Full Text] [Related]
34. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
35. SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-κB pathway activation.
Gao Y; Nan X; Shi X; Mu X; Liu B; Zhu H; Yao B; Liu X; Yang T; Hu Y; Liu S
BMC Cancer; 2019 Jul; 19(1):685. PubMed ID: 31299935
[TBL] [Abstract][Full Text] [Related]
36. miR-30 disrupts senescence and promotes cancer by targeting both p16
Su W; Hong L; Xu X; Huang S; Herpai D; Li L; Xu Y; Truong L; Hu WY; Wu X; Xiao C; Zhang W; Han J; Debinski W; Xiang R; Sun P
Oncogene; 2018 Oct; 37(42):5618-5632. PubMed ID: 29907771
[TBL] [Abstract][Full Text] [Related]
37. Defined p16
Grosse L; Wagner N; Emelyanov A; Molina C; Lacas-Gervais S; Wagner KD; Bulavin DV
Cell Metab; 2020 Jul; 32(1):87-99.e6. PubMed ID: 32485135
[TBL] [Abstract][Full Text] [Related]
38. Lack of a p16
Futami K; Sato S; Maita M; Katagiri T
Dev Comp Immunol; 2022 Aug; 133():104420. PubMed ID: 35417735
[TBL] [Abstract][Full Text] [Related]
39. p16INK4a-induced senescence is disabled by melanoma-associated mutations.
Haferkamp S; Becker TM; Scurr LL; Kefford RF; Rizos H
Aging Cell; 2008 Oct; 7(5):733-45. PubMed ID: 18843795
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cellular senescence and p16(INK4a) expression by Id1 and E47 proteins in human diploid fibroblast.
Zheng W; Wang H; Xue L; Zhang Z; Tong T
J Biol Chem; 2004 Jul; 279(30):31524-32. PubMed ID: 15138269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
